Cyklokapron Injection, Solution
Product Images NDC 0013-1114

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyklokapron (NDC 0013-1114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyklokapron 01)

Chemical structure of tranexamic acid, the active ingredient in Cyklokapron injection. The diagram depicts the molecule with a six-membered ring, an amino group, a carboxyl group, and associated bonds.*

FDA Label Image

Logo (Cyklokapron 02)

This is a label from Pfizer Laboratories for Cyklokapron injection, solution with tranexamic acid at 100 mg/mL strength. The label indicates distribution by Pfizer Inc, Division of Pfizer Inc, New York, NY 10017. The label features the Pfizer logo and is related to intravenous administration.*

FDA Label Image

Principal Display Panel (10 mL Ampule Label)

Cyklokapron 1,000 mg/10 mL injection solution label for intravenous use by Pfizer Laboratories Division of Pfizer Inc. The label identifies the product as tranexamic acid injection with a concentration of 100 mg/mL in a single-dose 10 mL ampule. It also includes directions to discard unused portions and features the NDC 0013-1114-01 along with a lot/expiration date area and a QR code.*

FDA Label Image

Principal Display Panel (10 mL Ampule Carton)

Packaging label for Cyklokapron 1000 mg/10 mL (100 mg/mL) tranexamic acid injection, a solution for intravenous use. The label states it contains 1 ampule of 10 mL, is single-dose only, and instructs to discard any remaining portion after use. It is labeled by Pfizer with distribution by Pharmacia & Upjohn Co, Division of Pfizer Inc, and made in Japan.*

FDA Label Image

Principal Display Panel (10 mL Ampule Carton)

Packaging label for Cyklokapron (tranexamic acid injection) 100 mg/mL, with a total strength of 1,000 mg per 10 mL ampule. The label specifies intravenous use only and single-dose ampule with instructions to discard unused portion. Distributed by Pfizer Laboratories Division of Pfizer Inc, made in Japan. Storage and dosage instructions are partially visible.*

FDA Label Image

Principal Display Panel (10 x 10 mL Ampule Box Label)

Packaging label for Cyklokapron tranexamic acid injection 1000 mg/10 mL (100 mg/mL) solution for intravenous injection. The label states it contains 10 ampules of 10 mL each, is single-dose only, and includes storage instructions. Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Cyklokapron (tranexamic acid injection) 1,000 mg/10 mL (100 mg/mL) intravenous injection. The label indicates a 10 mL vial, is marked Rx only, and is labeled for single-dose vial use. The product is distributed by Pfizer Labs, a division of Pfizer Inc, New York, NY.*

FDA Label Image

Principal Display Panel (10 mL Vial Box)

Packaging label for Cyklokapron (tranexamic acid injection) 1,000 mg/10 mL (100 mg/mL) intravenous solution. The carton contains 10 x 10 mL single-dose vials. Label shows instructions to discard unused portion and features Pfizer Injectables logo. The design includes red and black curved stripes and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.